Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 6Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Ovarian Neoplasms 1Non Small Lung Cancer 1Neoplasms by Site 1Lung Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Efficacy 1Carcinoma 1Bronchial Neoplasms 1Advanced Solid Tumors 1Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 2Injections 2toripalimab 1tislelizumab 1surufatinib 1sotorasib 1osimertinib 1netrin-1 inhibitor NP137 1lazertinib 1fluzoparib 1camrelizumab 1Panitumumab 1PM 01183 1Nivolumab 1Ipilimumab 1HMPL-013 1Erlotinib Hydrochloride 1Dexamethasone 1Calcium Dobesilate 1Bortezomib 1Bevacizumab 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Solid Tumors × sotorasib × Clear all
NCT07172919 2026-05-14

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

Amgen

Phase 2 Recruiting
14 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡